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“Sometimes, when we are threatened, we go to war, and sometimes we go to war against our 
own people. If we decided to wage war against cancer, would we do that by bombing the people 
who have cancer? Many nations have joined up to wage a war against drugs and have ended up 
attacking and harming people who really are in need of our help and our support.”
― Tuaru Potiki, UNGASS, 2016
The ways in which government officials address social problems such as poverty, disease, or 
crime are often affected by the terminology or rhetoric they use to describe them. What 
might be considered mere political hyperbole, at times has a deeper resonance and causes 
unintended consequences. In 2016, Tuari Potiki, an indigenous Māori who is also Chair of the 
New Zealand Drug Foundation, gave a speech at a special UN General Assembly.1 In his five-
minute allotment he outlined how that as a young 28-year-old, he was hauled before the courts 
on drug charges. Ordinarily, Potaki would have been jailed, yet the judge gave him a second 
chance by offering him a choice of health intervention, rather than jail. Potiki was convinced 
that if he had not been given that chance, he would have become another statistic of New 
Zealand’s war on drugs. Māori make up around 15% of the New Zealand population, yet 
represent 40% of those who are arrested for drug offences. A similar pattern of over 
representation in the incarcerated population occurs in indigenous peoples of Canada the 
United States and Australia （Potiki, 2016）.
The United Nations Office on Drugs and Crime’s World Drug Report 2012 estimated that 
cannabis usage in Oceania was nearly triple the global average （New Zealand Drug 
Foundation （NZDF）, 2013）. But this fact may not be so surprising in light of the historical 
facts regarding cannabis and other illicit usage in New Zealand. Until the 1920s there were 
few restrictions on drug usage and it was common for doctors to prescribe opium, cocaine and 
cannabis for common ailments. They were also commonly used for recreation （Hil, & Tait, 
2004） However, in line with many other Western countries, New Zealand introduced 
legislation in 1927 to prevent the distribution of narcotics outside of medical use （Hil, & Tait, 
2004）. It was then that New Zealand began to crack down hard on drugs, with the 





government coming to view them as having the potential to cause wide-spread community 
decay and contribute to crime and social disorder. It was in the 1960s, that the spread of the 
hippie movement contributed to an uptake of illicit drug use, particularly marijuana （Hil, R., & 
Tait, 2004）. Following this, there began a series of law changes, culminating with the 
introduction of the Misuse of Drugs Act 1975, which strictly enforced the control of drugs.
Under the Act, it is also forbidden to cultivate prohibited plants, such as cannabis, which can 
lead to seven years imprisonment. Finally, possessing the seed or fruit of a prohibited plant 
can lead to a one-year imprisonment and/or $500 dollar fine （New Zealand Police）. And, 
although the Act has been updated over the years,2 the original three classes remain. The 
maximum penalty for dealing in Class A drugs is imprisonment for life; a Class B drug 14 
years; and a Class C drug eight years （Table 1）.
Although the use of cannabis was classified as a Class C drug, which is the least strict class of 
drug the fact is that even Class C drugs included stiff fines and the likelihood of imprisonment 
for the supply or its manufacture. One of the most damaging parts of the law was the charge 
of allowing your premises or motor vehicle to be used by someone to make, use or carry 
drugs. This charge could result in up to three years imprisonment, similar to asset forfeiture 
laws in the United States that allow confiscation of physical property used, even tangentially, 
in the drug trade. In comparison, the cultivation of cannabis could lead to two years in jail and 
or a $2,000 fine.
Table 1: Classification of drugs, according to the Misuse of Drugs Act, 1975
Type of penalty
Class Drug type For possession
For supply
or manufacture
For allowing your property 
or vehicle to be used to 











Life imprisonment 10 years imprisonment
B
（High）
cannabis oil, hashish, 
morphine, opium, 



















Indictment ― 8 years 
imprisonment. 
Summarily ― 1 year 
jail and/or $1,000 fine
3 years imprisonment
Source: https://www.police.govt.nz/advice/drugs-and-alcohol/illicit-drugs-offences-and-penalties （Compiled by author）
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Changing Attitudes
The Misuse of Drugs Act strictly criminalised drugs according to class, leading to a situation 
in which even simple possession of any class of drug according to the Act could lead to a simple 
fine, or even jail time. Enforcement of the Act is problematic as it fails to define how much of a 
drug one could possess before it is deemed supply （leading to a stricter penalty）. This has led 
to many inconsistencies in the application of the law, especially for Māori, who tend to be overly 
persecuted and discriminated against under the Act. （MacLennan, 2016; Enoka M, 2016）.
A government health survey found that 25% of Māori adults had used cannabis within the 
past 12 months, compared to just 11% of Europeans. They also found a connection with Māori 
poverty and cannabis use, with Māori in poorer areas reporting using cannabis weekly 
（Cannabis Use 2012/13）. And while Māori account for just 15% of the population of New 
Zealand, Māori aged between 17-25% account for 37% of those convicted of possession of an 
illegal drug. Regarding Māori youth, “a combination of early and regular cannabis use 
negatively impacts on young people’s health and wellbeing . . . . they are more likely to be 
criminalised for its use from a young age even when they have similar levels of use to non-
Māori.” （Reremoana, Ngāpuhi, et al, 2020）.
While the social and health ills are tragic on a personal level, it can be difficult to picture how 
they affect society as a whole. One way is with a cold economic calculus, and the Ministry of 
Health estimated that the social costs, including personal, community harm and interventions, 
due to the abuse of all classes of illicit drugs was 1.8 billion dollars （The New Zealand Drug 
Harm Index, 2016）. The report emphasizes that illicit drug use is not just a personal issue, but 
one that has a wide social and economic impact.
In 2007, the New Zealand Law Commission was commissioned to undertake a review of drug 
policy in New Zealand. One of the commission’s recommendations was a move toward 
accepting that drug use is primarily a health issue and should be addressed through health-
based approaches. In the report, the commission defines harm minimisation as, “an approach 
that is designed to limit the overall harms that result from the consumption of drugs” （2011, p. 
37）. In their final report, the commission recommended repealing the Misuse of the Drugs 
Act, 1975 and replacing it with a new one, to be implemented by the Ministry of Health, which 
would include modifying the criteria and approval process for regulating new classes of 
psychoactive substances. It would continue to have strict penalties against large-scale 
commercial dealing of illicit drugs, yet be more flexible regarding small-scale dealing and 
personal possession and use, especially in cases of drug dependency. As a result of the report, 
the government agreed that the Act should be replaced, and new legislation developed for 
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unregulated psychoactive substances （Misuse of Drugs Act 1975）. Such an approach attacks 
the government’s issues with illicit drugs in several ways: it discourages supply by providing 
for strict criminal punishment for large suppliers, and protects individual users from becoming 
criminals, while treating their underlying health problems.
The New Zealand Drug Foundation （NZDF） is committed to reducing and preventing the social 
and health harm caused by illicit and licit drugs in New Zealand.3 According to the NZDF, drugs 
can, “cause social, health and economic harms, and the ongoing cost to individuals, Whanau 
（families） and communities is high.” However, “Our current drug laws are no longer fit for 
purpose, and do not address those harms. We want the government to take a more 
compassionate approach to drugs, and to support people who are struggling instead of punishing 
them.” In their Statement of Directions 2018-22, they outline four ideal outcomes:
Ⅰ: Schools keep young people engaged in education.
Ⅱ: Laws are changed to treat drug use as a health issue.
Ⅲ:  Prevention, harm reduction and treatment interventions are fully resourced and are 
made more responsive to community need.
Ⅳ:  Innovative solutions to reducing drug harm are developed that supported communities 
to respond to new challenges.
These proposals reflect a humanistic approach to mitigating the negative effects of drug use 
and drug enforcement policy. They add a human element to the crime statistics and consider 
the social impact of the stigma of a criminal record for what is popularly considered a minor 
offence. The increasing social acceptance of cannabis use also drove a movement in New 
Zealand and around the world to not only change enforcement priorities, but to legalise 
cannabis completely and regulate it on par with alcohol and tobacco.
The 2020 Cannabis Referendum
In recent years, there has been a move in New Zealand toward a more hands-off approach to 
the use of drugs, in particular for personal use, with the Police encouraged to take a softer 
stance on the possession of class C drugs, which includes cannabis. There were several 
reasons for the desire for reform of cannabis regulations. According to the New Zealand Drug 
Foundation, 80% of New Zealanders had tried cannabis by the age of 21. New Zealanders are 
estimated to consume as much as 8.9 million dollars of illicit drugs per week, to the point that 
it is detectable in municipal wastewater treatment centres （Leanz, 2019）. It is clear the 
current laws do not deter many people from using illicit drugs, most of all cannabis; indeed 
the government must invest a great deal of time and resources on enforcement which is a 
huge cost to taxpayers. There is a disproportionate effect on Māori, who are three times more 
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likely to get a cannabis conviction than someone of European descent for the same level of use 
and are twice as likely as the national norm to suffer a substance use disorder. Māori also 
have less access to health and treatment services.
The proposed legislation （Refer to Appendix 2） was designed to “reduce the harms associated 
with cannabis use experienced by individuals, families, whānau, and communities.” 
（Parliamentary Counsel, 2019）. Cannabis Legalisation and Control Bill Draft）. The new regime 
would: 1. Raise public awareness of the risks associated with cannabis consumption; 2. improve 
access to health and other relevant support services; 3. restrict young people’s access to 
cannabis and limit public visibility to cannabis; and 4. provide access to a legal and quality-
controlled supply of cannabis for those aged 20 or older （Parliamentary Counsel, 2019）. Even 
the New Zealand Medical Journal encouraged New Zealanders to vote in favour of change, in 
a “once-in a lifetime opportunity.”
The Cannabis Referendum, which was non-binding, was held on 17th of October 2020 along 
with the 2020 general election which included a referendum on euthanasia. The referendum 
questioned voters whether they agreed on the legalisation of the sale, use, possession and 
production of cannabis （Appendix 1）. In the months leading up to the referendum, there was 
much debate for and against, with polls showing a pretty much even split in the electorate. 
Although the referendums were technically non-binding, Prime Minister Jacinda Ardern 
publicly stated that the government would respect the decision of the electorate. Opinion polls 
just before the referendum indicated that the trend was for younger votes under the age of 
40 and the overwhelming majority of Māori to be in favour of the proposed law change.4 In 
the end, the “No” vote only just edged out the “Yes” vote by 48.4% to 50.7%. Although it 
ultimately did not pass, it is notable that a referendum on this topic would even be put forth 
for consideration, let alone have such a close result. However, it may not be so surprising as 
New Zealand has consistently been a leader in many social issues, such as being the first 
country in the world to grant women the vote and the first to recognize same-sex marriage.
Lessons from Canada
It is clear that there is changing sentiment in New Zealand regarding the legalisation of 
cannabis, and even an indication that the government may push ahead independently to 
reform drug laws towards a harm-reduction approach and eventual legalization of some “soft” 
drugs. For a vision of what the social and economic effects of full legalisation would be, it is 
useful to look at the example of Canada to see the benefits and pitfalls of cannabis legalisation.
On June 18th, 2018 Canadian lawmakers voted 205-82 to legalize its recreational use （Anapol, 
2018）, making it the second country after Uruguay to do so （Watson & Erickson, 2019）. These 
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changes were implemented as a result of being included as a part of the Trudeau government’s 
2015 election platform that was partly responsible for his election （Watson & Erickson, 2019）. 
Following the public debate and formal guidelines, official legalization began on October 17th, 
2018 （Tasker, 2018）.
In the process of legalisation, the government’s objectives are both to create a healthier 
product for consumption by youth and to remove profits from criminal organizations in the 
name of public safety （Watson & Erickson, 2019）. Another aspect of the plan was the fairness 
issue of trying to address the plight of marginalized minorities who were disproportionately 
affected by criminal involvement in “soft” drugs. （Austen, 2021） In the implementation there 
were ten recommendations that were introduced referred to as the Lower-Risk Cannabis Use 
Guidelines （LRCUG） （Table 2）, （Fischer, et al., 2019）.
In the two years since legalisation, there have been a number of changes, including the legal 
reforms that allowed those that were convicted of earlier drug offences to have criminal 
offences expunged from records. Austen （2021）, points out that “in 2018, the police recorded 
26,402 possession cases until legalisation went into effect in mid-October. In 2019, that number 
dropped to 46”. A recent study analysed the newly expanded cannabis industry and found 
that “Black and Indigenous people, and women, are vastly underrepresented in leadership 
positions in the Canadian cannabis industry . . . while white men overrepresented” （Maghsoudi, 
et al., 2020）. So, while the legal changes have allowed minorities to be free from higher 
incarceration rates, the economic market is not free. One unintended consequence is that 
success of a legal cannabis market which focuses on high-end consumers and expensive 
boutique strains, coupled with relatively high “vice taxes” may prove to be too expensive for 
the lower-income users who in turn will have to resort to creating new black markets for 
cannabis, perpetuating the cycle or criminality.
One issue with legalisation is the false perception by the public, especially those inexperienced 
with cannabis use, that if the government says a product is “legal” it is also implied to be 
“safe.” It is true that almost anything can be toxic in high enough doses, even water. A 
common cause of drug-related death is an “overdose” of water （hyponatraemia） by users of 
MDMA （“ecstasy”） because the drug’s stimulant effects cause users to want to drink an 
excessive amount of water （Baggot et al., 2016）. There needs to be more guided research into 
the long-term health effects of these “soft” drugs. Cannabis products have many purported 
health benefits, but also significant risks to short-term physical or mental impairment, lung 
damage （if smoked）, and perhaps exacerbated mental illness. Fisher, et al. （2019） have 





Recommendation 1: The most effective way to avoid any risks of cannabis use is to 
abstain from use. Users should recognize the acute and long-term adverse health and 
social outcomes. These risks will vary in their likelihood and severity with user 
characteristics, use patterns, and product qualities, and so may not be the same from user 
to user or from episode to episode.
None 
required
Recommendation 2: Early initiation of cannabis use （i.e., before age 16 years） is associated 
with multiple subsequent adverse health and social effects in young adult life, particularly 
in frequent or intensive usage. This may be in part because frequent cannabis use affects 
the developing brain. Prevention messages should emphasize that, the later cannabis use 
is initiated, the lower the risks will be for adverse effects on the user’s general health and 
welfare throughout later life.
Substantial
Recommendation 3: High THC-content products are generally associated with higher 
risks of various （acute and chronic） mental and behavioral problem outcomes. Users 
should know the nature and composition of the cannabis products that they use, and 
ideally use cannabis products with low THC content and relatively higer CBD content.
Substantial
Recommendation 4: Recent reviews on synthetic cannabinoids indicate markedly more 
acute and severe adverse health effects from the use of these products （including 
instances of death）. The use of these products should be avoided. 
Limited
Recommendation 5: Regular inhalation of combusted cannabis adversely affects 
respiratory health outcomes. It is generally preferable to avoid routes of administration 
that involve smoking combusted cannabis material （e.g., by using vaporizers or edibles）. 
Use of edibles eliminates respiratory risks, but the delayed onset of psychoactive effect 
may result in the use of larger than intended doses and subsequently increased （mainly 
acute, e.g., from impairment） adverse effects.
Substantial
Recommendation 6: Users should avoid practices such as “deep inhalation,” breath-holding, 
or the Valsalva maneuver to increase psychoactive ingredient absorption when smoking 
cannabis, as these practices disproportionately increase the intake of toxic material into 
the pulmonary system.
 Limited
Recommendation 7: Frequent or intensive （e.g., daily or near-daily） cannabis use is 
strongly associated with higher risks of experiencing adverse health and social outcomes 
related to cannabis use. Users should be aware and vigilant to keep their own cannabis 
use to approximately once a week. 
 Substantial
Recommendation 8: Driving while impaired from cannabis is associated with an increased 
risk of involvement in motor-vehicle accidents. Users should wait a minimum of 6 hours 
before driving. Besides these behavioral recommendations, users are bound by locally 
applicable legal limits concerning cannabis impairment and driving. The use of both 
cannabis and alcohol results in multiplied increased impairment and risks for driving, and 
categorically should be avoided.
Substantial
Recommendation 9: Some populations that have probable higher risk for cannabis-related 
adverse effects include individuals with predisposition for, or a first-degree family history 
of, psychosis and substance use disorders, as well as pregnant women （primarily to avoid 
adverse effects on the fetus or newborn）.
Substantial
Recommendation 10: While data are sparse, it is likely that the combination of some of 
the risk behaviors listed above will magnify the risk of adverse outcomes from cannabis 
use. For example, early-onset use involving frequent use of high-potency cannabis is likely 
to disproportionately increase the risks of experiencing acute or chronic problems. The 
combination of these high-risk patterns of use should be avoided by the user and a focus 
should be placed on prevention.
Limited
Source: Fischer et al. （2019）.
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Conclusion
New Zealand, along with many other countries around the world has realised that that the 
war on drugs that began in the 1970s has failed and inflicted much pain and hardship on 
many communities, especially the indigenous Maori, that have been severely impacted by out-
of-date drug laws that tend to discriminate based on ethnicity. It is evident that current drug 
laws in New Zealand are not fit for purpose, and in urgent need of reform. It is heartening 
to see a move toward softer penalties for drug use combined with harm reduction measures, 
but ultimately, the way forward will probably be some form of decriminalisation and then 
eventually legalization, as has happened in several overseas jurisdictions. New Zealand can 
avoid the unanticipated consequences of these changes in the legal framework by learning 
from Canada’s experiences, in particular, the impact on minority and indigenous communities. 
Economic opportunities will arise from legalisation, it is important that the benefits trickle into 
the wider society. Employment opportunities will boost the economy. Legalised sales will also 
provide opportunities to raise taxes on cannabis products which can be used to fund harm 
mitigation programs to treat drug dependency. Towards the end of the Cold War, the changes 
in long-standing political rivalries between the United states and the Soviet Union resulted in 
corresponding changes in policies and priorities. Politicians of the day promised a “peace divi-
dend” in which the government funds allocated to the military buildup would be reallocated to 
social programs, economic development, or education. It is hopeful that if the drug war were 
to call a ceasefire, there could be a resulting peace dividend.
Acknowledgements
The author wishes to thank Professor Richard Miller of Osaka Jogakuin University, a First Nations person 
with status under the Indian Act of Canada, who is active in his tribe in Canada; and Professor Michael 
Parrish of Kwansei University who kindly provided input and advice on this paper.
《Notes》
1 Speaking at the Special session of the United Nations General Assembly on the World Drug Problem 
（UNGASS） 2016.
2 In 2019, several important amendments were made to the Act. Several synthetic cannabinoids 
became Class A drugs, the police were given more discretion to prosecute for possession and use of 
controlled drugs, and the possibility of temporary class of drug orders was introduced. See:https://
www.health.govt.nz/our-work/mental-health-and-addiction/mental-health-legislation/changes-misuse-
drugs-act
3 The New Zealand Drug Foundation is a charity that is supported by government funding, as well as 
by private grants and donations and members.
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Appendix 2  Copy of Proposed Cannabis Bill （2019）
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